// App-Quantinova.ai

5938 : Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies

Researchers

Presenter

  • D. Gaudet

Principal Investigators

  • N/A

Medical Centers

  • Université de Montréal, The ECOGENE-21 Clinical Research Center and Lipid Clinic, Department of Medicine, Chicoutimi, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • evinacumab

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

Phase

  • NA

Study Id's

  • NCT02265952

Sponsors

  • Regeneron Pharmaceuticals

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved